½ÃÀ庸°í¼­
»óǰÄÚµå
1467753

¾à±¹ ÀÚµ¿È­ ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Pharmacy Automation Market Report by Product Type, Application, End-User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾à±¹ ÀÚµ¿È­ ½ÃÀå ±Ô¸ð´Â 2023³â 63¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2024-2032³â 6.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸À̸ç 2032³â±îÁö 117¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÇ·á ÇÁ·Î¼¼½º¿¡¼­ ¿À·ù¸¦ ÁÙ¿©¾ß ÇÒ Çʿ伺 Áõ°¡, ¸¸¼º ÁúȯÀÇ Áõ°¡, ·Îº¿ °øÇÐ, ÀΰøÁö´É, ±â°è ÇнÀ ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ´Ù¾çÇÑ ¹ßÀüÀº ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

¾à±¹ ÀÚµ¿È­´Â ¾à±¹ ¾÷¹«ÀÇ ´Ù¾çÇÑ Ãø¸éÀ» °£¼ÒÈ­ÇÏ°í °³¼±Çϱâ À§ÇØ ±â¼ú°ú ÀÚµ¿È­ ½Ã½ºÅÛÀ» »ç¿ëÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ±âÁ¸¿¡´Â ¾à»ç³ª ¾à±¹ Á÷¿øÀÌ ¼öÀÛ¾÷À¸·Î ¼öÇàÇÏ´ø ÀÛ¾÷À» ·Îº¿ Àåºñ, ÄÄÇ»ÅÍ ½Ã½ºÅÛ, ¼ÒÇÁÆ®¿þ¾î ¾ÖÇø®ÄÉÀ̼ÇÀ» ÅëÇØ ¼öÇàÇÕ´Ï´Ù. ¶ÇÇÑ Á¶Á¦, Àç°í °ü¸®, ó¹æÀü ÀÛ¼º ¹× ±âŸ ÀǾàǰ ÇÁ·Î¼¼½ºÀÇ È¿À²¼º, Á¤È®¼º ¹× ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ȯÀÚ ¾ÈÀü Çâ»ó, Åõ¾à ¿À·ù °¨¼Ò, È¿À²¼º Çâ»ó, Àç°í °ü¸® °­È­, ¾à±¹ Á÷¿øÀÇ ¿öÅ©ÇÃ·Î¿ì °³¼± µî ´Ù¾çÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù.

ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ÁÖ·Î ÀÇ·á ÇÁ·Î¼¼½º¿¡¼­ ¿À·ù¸¦ ÁÙ¿©¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Àα¸ °í·ÉÈ­¿Í ¸¸¼º ÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ó¹æ¾à¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾à±¹ ÀÚµ¿È­¸¦ ÅëÇØ ¾à±¹Àº ´ë·®ÀÇ Ã³¹æÀüÀ» È¿À²ÀûÀ¸·Î ó¸®ÇÏ¿© Àû½Ã¿¡ Á¶Á¦Çϰí ȯÀÚÀÇ ´ë±â ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾çÁúÀÇ ÀÇ·á ½Ã¼³À» ±¸ÇöÇϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ Á¤Ã¥ÀÇ ½ÃÇ൵ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ È¿À²ÀûÀΠȯÀÚ Ä¡·á¿Í ÇÔ²² Ä¡·á ¹× ¼ö¼ú ÈÄ ¼º°ø·üÀÌ Çâ»óµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ÁÁÀº ½ÃÀå Àü¸ÁÀ» ³º°í ÀÖ½À´Ï´Ù. ¾à±¹ ÀÚµ¿È­´Â Åõ¾à ½Ç¼ö À§ÇèÀ» ÁÙÀ̰í, Á¶Á¦ Á¤È®µµ¸¦ ³ôÀ̰í, ¸íÈ®ÇÑ ¾à¹° ¶óº§¸µÀ» Á¦°øÇÏ¿© ȯÀÚ ¾ÈÀüÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÚµ¿È­µÈ ó¹æÀü ¸®ÇÊ ½Ã½ºÅÛ ¹× ¾à¹° Æ÷Àåµµ ȯÀÚÀÇ ÆíÀǼºÀ» ³ôÀÌ°í ¾à¹°¿¡ ´ëÇÑ Á¢±Ù°ú °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© ¶Ç ´Ù¸¥ ÁÖ¿ä ¼ºÀå µ¿·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¾à±¹ ÀÚµ¿È­ ½ÃÀå µ¿Çâ ¹× ÃËÁø¿äÀÎ:

ÀÇ·á ÇÁ·Î¼¼½ºÀÇ ¿À·ù °¨¼Ò¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡

Åõ¾à ¿À·ù´Â ȯÀÚÀÇ ¾ÈÀü°ú À£ºù¿¡ ½É°¢ÇÑ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÇ·á Á¦°øÀÚ¿Í ¾à±¹Àº ¿À·ùÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¾à±¹ ÀÚµ¿È­ ¼Ö·ç¼ÇÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛÀ̳ª ¹ÙÄÚµå ½ºÄ³´× ±â¼ú°ú °°Àº ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Åõ¾à ¿À·ù¸¦ ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Á¤È®ÇÑ Á¶Á¦, ó¹æÀü È®ÀÎ, ó¹æÀü ÁÖ¹®°ú ȯÀÚ ÇÁ·ÎÇÊÀÇ ¸ÅĪÀ» Áö¿øÇÏ¿© ÀÎÀû ¿À·ùÀÇ °¡´É¼ºÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ, °øµ¿À§¿øÈ¸(Joint Commission)¿Í ½ÄǰÀǾ౹(FDA)°ú °°Àº ±ÔÁ¦ ±â°üÀº ¾à¹° ¾ÈÀü¿¡ ´ëÇÑ Á߿伺À» °­Á¶Çϸç ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ½Ç¼ö¸¦ ÁÙÀ̱â À§ÇÑ Á¶Ä¡¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ °­È­·Î ÀÎÇØ ÄÄÇöóÀ̾𽺠±âÁØÀ» ÃæÁ·Çϱâ À§ÇÑ ¾à±¹ ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

·Îº¿°øÇÐ, ÀΰøÁö´É, µ¥ÀÌÅÍ ºÐ¼®ÀÇ ´Ù¾çÇÑ ±â¼ú ¹ßÀü

·Îº¿ Á¶Á¦ ½Ã½ºÅÛÀº ¾àǰÀ» Á¤È®ÇÏ°Ô °è»êÇÏ°í Æ÷ÀåÇÏ¿© ½Ç¼ö¸¦ ÁÙÀ̰í È¿À²¼ºÀ» ³ôÀ̸ç, ·Îº¿ Á¶Á¦ ½Ã½ºÅÛÀº ´ë·®ÀÇ Ã³¹æÀüÀ» ó¸®ÇÒ ¼ö ÀÖ¾î º¸´Ù ºü¸£°í Á¤È®ÇÑ Á¶Á¦°¡ °¡´ÉÇÕ´Ï´Ù. ÀÌ ·Îº¿Àº ´ë·®ÀÇ Ã³¹æÀüÀ» ó¸®ÇÒ ¼ö ÀÖ¾î º¸´Ù ºü¸£°í Á¤È®ÇÑ Á¶Á¦¸¦ ½ÇÇöÇÒ ¼ö ÀÖÀ¸¸ç, AI ¹× ML ¾Ë°í¸®Áò°ú ÅëÇÕµÈ ·Îº¿ ½Ã½ºÅÛÀº µ¥ÀÌÅÍ ÆÐÅÏÀ¸·ÎºÎÅÍ ÇнÀÇÏ¿© Á¶Á¦ ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈ­ÇÏ°í º¯È­ÇÏ´Â ¾à±¹ÀÇ ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ¹× ML ¾Ë°í¸®ÁòÀº ¾à±¹ ÀÚµ¿È­ÀÇ ´Ù¾çÇÑ Ãø¸éÀ» °³¼±Çϱâ À§ÇØ È°¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ȯÀÚ µ¥ÀÌÅÍ, ¾à¹° ÀÌ·Â, ¾à¹° »óÈ£ ÀÛ¿ëÀ» ºÐ¼®Çϰí ÀÓ»ó ÀÇ»ç °áÁ¤ Áö¿øÀ» Á¦°øÇÏ¿© ¾à»ç°¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ºÐ¼® µµ±¸´Â ¾à¹° »ç¿ë ÆÐÅÏÀ» ºÐ¼®Çϰí, Ãß¼¼¸¦ ÆÄ¾ÇÇϰí, Àç°í ¼öÁØÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®´Â ¾à±¹ÀÌ Àç°í ¼öÁØ Á¶Á¤, Á¶Á¦ ÆÐÅÏ ÆÄ¾Ç, ¾÷¹« È¿À²¼º °³¼± µî µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ¾î ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ Áõ°¡

¸¸¼ºÁúȯÀº Àå±âÀûÀÎ Åõ¾à °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹¾Æ ó¹æÀü ¼ö°¡ Å©°Ô Áõ°¡ÇÕ´Ï´Ù. ·Îº¿ Á¶Á¦ ½Ã½ºÅÛ ¹× ó¹æÀü ÀÛ¼º ÀÚµ¿È­¿Í °°Àº ¾à±¹ ÀÚµ¿È­ ½Ã½ºÅÛÀº ¾à±¹ÀÌ ´ë·®ÀÇ Ã³¹æÀüÀ» È¿À²ÀûÀ¸·Î ó¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÚµ¿È­ ½Ã½ºÅÛÀº Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Á¶Á¦¸¦ º¸ÀåÇϰí ȯÀÚ ´ë±â ½Ã°£À» ´ÜÃàÇÏ¸ç ¾à±¹ÀÇ Àü¹ÝÀûÀÎ ¿öÅ©Ç÷ο츦 °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾à±¹ ÀÚµ¿È­´Â ÀÚµ¿ ó¹æÀü ¸®ÇÊ ½Ã½ºÅÛ ¹× ¾à¹° Æ÷Àå ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á º¹¾à ¼øÀÀµµ¸¦ ³ôÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚ´Â Æí¸®ÇÏ°Ô ¾àÀ» ¹ÞÀ» ¼ö ÀÖ°í, ÃæºÐÇÑ ¾çÀ» È®º¸ÇÒ ¼ö ÀÖÀ¸¸ç, ¾à º¹¿ëÀ» Àؾî¹ö¸± °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¾à±¹ ÀÚµ¿È­ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛ
  • ÀÚµ¿ â°í(ASRS)
  • ÀÚµ¿ Æ÷À塤¶óº§¸µ ½Ã½ºÅÛ
  • Ź»ó Á¤Á¦ Ä«¿îÅÍ
  • ±âŸ

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • Á¶Á¦¡¤Æ÷Àå
  • ÀǾàǰ º¸°ü
  • Àç°í °ü¸®

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
    • Æä·ç
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ÅÍŰ
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • À̶õ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Capsa Healthcare
    • Cerner Corp.
    • Kirby Lester LLC
    • KUKA AG
    • McKesson Corporation
    • Omnicell Technologies
    • RxSafe LLC
    • Scriptpro LLC
    • Swisslog Holding AG
    • Takazono Corp.
    • Talyst LLC
    • TCGRx Pharmacy Workflow Solutions
    • Yuyama Co. Ltd.
ksm 24.05.07

The global pharmacy automation market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increasing need to reduce errors in medical processes, the growing prevalence of chronic diseases, and various advances in robotics, artificial intelligence, machine learning, and data analytics are some of the major factors propelling the market.

Pharmacy automation refers to the use of technology and automated systems to streamline and improve various aspects of pharmacy operations. It involves the use of robotic devices, computerized systems, and software applications to perform tasks that were traditionally carried out manually by pharmacists and pharmacy staff. It also aims to enhance efficiency, accuracy, and safety in medication dispensing, inventory management, prescription filling, and other pharmaceutical processes. These solutions offer various benefits such as improved patient safety, reduced medication errors, increased efficiency, enhanced inventory management, and improved workflow for pharmacy staff.

The market is primarily driven by the increasing need to reduce errors in medical processes. In addition, with the aging population and increasing prevalence of chronic diseases, the demand for prescription medications has been on the rise. Pharmacy automation enables pharmacies to handle larger prescription volumes efficiently, ensuring timely dispensing and reducing waiting times for patients. Besides, the implementation of various government policies to make quality healthcare facilities is also contributing to market growth. Moreover, various technological advancements are resulting in higher success rates post-treatment and surgeries, along with the delivery of efficient patient care which is also creating a favorable market outlook across the globe. Pharmacy automation enhances patient safety by reducing the risk of medication errors, improving accuracy in dispensing, and providing clear medication labeling. Automated prescription refill systems and medication packaging also enhance convenience for patients, making it easier to access and manage their medications, representing another major growth-inducing factor.

Pharmacy Automation Market Trends/Drivers:

The increasing need to reduce errors in medical processes

Medication errors can have severe consequences on patient safety and well-being. As a result, healthcare providers and pharmacies are increasingly adopting pharmacy automation solutions to minimize the risk of errors and improve patient outcomes. These systems, such as automated dispensing systems and barcode scanning technology, play a crucial role in reducing medication errors. They help ensure accurate medication dispensing, verify prescriptions, and cross-reference medication orders with patient profiles, minimizing the potential for human errors. Moreover, regulatory bodies, such as the Joint Commission and the Food and Drug Administration (FDA), also place importance on medication safety and require healthcare providers to implement measures to reduce errors. This regulatory push further accelerates the adoption of pharmacy automation solutions to meet compliance standards.

Various technological advancements in robotics, artificial intelligence and data analytics

Robotic dispensing systems can accurately count and package medications, reducing errors and enhancing efficiency. These robots can handle a high volume of prescriptions, ensuring faster and more precise medication dispensing. Robotic systems integrated with AI and ML algorithms can even learn from data patterns to optimize medication dispensing processes and adapt to changing pharmacy needs. Moreover, AI and ML algorithms are being utilized to improve various aspects of pharmacy automation. These technologies can analyze patient data, medication histories, and drug interactions to provide clinical decision support, helping pharmacists make informed decisions. Besides, data analytics tools can analyze medication usage patterns, identify trends, and optimize inventory levels. These insights help pharmacies make data-driven decisions, such as adjusting stock levels, identifying medication dispensing patterns, and improving operational efficiency, thus propelling the market growth.

The growing prevalence of chronic diseases

Chronic diseases often require long-term medication management, leading to a significant increase in prescription volumes. Pharmacy automation systems, such as robotic dispensing systems and prescription filling automation, enable pharmacies to handle larger prescription volumes efficiently. Automated systems ensure accurate and timely medication dispensing, reducing waiting times for patients and improving overall workflow in pharmacies. Moreover, pharmacy automation plays a crucial role in promoting medication adherence by providing automated prescription refill systems and medication packaging solutions. These systems help patients conveniently receive their medications, ensuring they have a sufficient supply and reducing the likelihood of missed doses, thus contributing to market growth.

Pharmacy Automation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmacy automation market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, application and end-user.

Breakup by Product Type:

Automated Medication Dispensing Systems

Automated Storage & Retrieval Systems

Automated Packaging & Labeling Systems

Tabletop Tablet Counters

Others

Automated medication dispensing systems represents the leading segment

The report has provided a detailed breakup and analysis of the market based on the product type. This includes automated medication dispensing systems, automated storage & retrieval systems, automated packaging & labeling systems, tabletop tablet counters, and others. According to the report, automated medication dispensing systems represented the largest segment.

Automated medication dispensing systems ensure precise medication dosing and reduce the risk of human errors. These systems employ barcode scanning and verification, medication database integration, and robotic dispensing technology to accurately dispense medications. Moreover, these systems streamline the medication dispensing process, saving time and improving operational efficiency in pharmacies. They can handle a large volume of prescriptions quickly and accurately, reducing waiting times for patients and optimizing workflow for pharmacy staff. Besides, automated medication dispensing systems often include inventory management functionalities, enabling real-time tracking of medication stock levels, expiration dates, and batch numbers. This integration ensures efficient inventory control, reducing the risk of medication shortages or wastage.

Breakup by Application:

Drug Dispensing and Packaging

Drug Storage

Inventory Management

Drug dispensing and packaging hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes drug dispensing and packaging, drug storage, and inventory management. According to the report, drug dispensing and packaging accounted for the largest market share.

Drug dispensing and packaging are essential steps in the medication workflow process within pharmacies. Automation solutions that focus on drug dispensing and packaging address the need for accurate and efficient medication management. These systems streamline the process by automating tasks such as counting pills, verifying prescriptions, labeling medications, and packaging them for individual patients. The ability to automate these critical steps significantly improves workflow efficiency and reduces the potential for errors, leading to increased demand for these automation solutions. Besides, these automation systems often incorporate barcode scanning, medication verification, and advanced algorithms to ensure accurate medication dispensing and packaging, enhancing patient safety and reducing adverse drug events.

Breakup by End-User:

Hospital Pharmacies

Retail Pharmacies

Others

Retail pharmacies exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and others. According to the report, retail pharmacies accounted for the largest market share.

Retail pharmacies cater to a large volume of patients, serving as accessible points of care within communities. The high footfall and patient demand drive the need for efficient and streamlined pharmacy operations, making retail pharmacies a significant market segment for pharmacy automation solutions. Moreover, retail pharmacies often prioritize customer convenience and aim to differentiate themselves through superior service. Pharmacy automation solutions contribute to this goal by reducing waiting times, minimizing medication errors, and enhancing overall customer experience, thus accelerating the product adoption rate.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Saudi Arabia

Iran

United Arab Emirates

Others

North America accounts for the majority of market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America holds the largest market share for pharmacy automation solutions.

North America has been at the forefront of technological advancements, including pharmacy automation. The region has a robust healthcare infrastructure and a high level of adoption and investment in advanced technologies. This has led to the development and deployment of innovative pharmacy automation solutions, making North America a leading market for these technologies. Moreover, the region has stringent regulatory standards for medication safety and quality control. The regulatory bodies, such as the Food and Drug Administration (FDA) in the United States, prioritize patient safety and require compliance with specific guidelines for medication dispensing and management. Pharmacy automation solutions help pharmacies meet these standards and ensure accurate and safe medication dispensing, making them highly sought after in the region.

Competitive Landscape:

The competitive landscape of the pharmacy automation market is characterized by the presence of several key players competing for market share. These companies offer a range of pharmacy automation solutions and constantly innovate to stay ahead in the market. At present, key players are developing advanced pharmacy automation solutions that address the evolving needs of healthcare providers and pharmacies. This includes improving accuracy, expanding functionalities, integrating artificial intelligence and machine learning capabilities, and enhancing user experience. They are also collaborating with healthcare systems, retail pharmacy chains, and other industry stakeholders to integrate their automation solutions with existing healthcare infrastructure. Moreover, these players are expanding their presence in different geographic regions by targeting untapped markets.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Baxter International Inc.

Becton Dickinson and Company

Capsa Healthcare,

Cerner Corp.

Kirby Lester LLC,

KUKA AG

McKesson Corporation

Omnicell Technologies

RxSafe LLC

Scriptpro LLC

Swisslog Holding AG

Takazono Corp.

Talyst LLC

TCGRx Pharmacy Workflow Solutions

Yuyama Co. Ltd.

Recent Developments:

In 2022, Capsa Healthcare made an announcement regarding the acquisition of Humanscale Healthcare, a New York-based company specializing in flexible technology solutions and computing workstations. This strategic acquisition has enabled Capsa Healthcare to expand its product suite significantly, positioning itself as a leader in the market.

In 2021, Omnicell, Inc. completed the acquisition of ReCept Holdings, Inc. This acquisition broadened Omnicell's Advanced Services portfolio by incorporating specialty pharmacy management services tailored to health systems, provider groups, and federally qualified health centers (FQHCs).

In 2021, Swisslog Healthcare entered into an innovation agreement with Centre Hospitalier - Le Mans. The collaboration aims to leverage their combined expertise in the pharmacy field, focusing on the development and implementation of TheraPick, an automated packaging and dispensing system.

Key Questions Answered in This Report

  • 1. How big is the global pharmacy automation market?
  • 2. What is the expected growth rate of the global pharmacy automation market during 2024-2032?
  • 3. What are the key factors driving the global pharmacy automation market?
  • 4. What has been the impact of COVID-19 on the global pharmacy automation market?
  • 5. What is the breakup of the global pharmacy automation market based on the product type?
  • 6. What is the breakup of the global pharmacy automation market based on the application?
  • 7. What is the breakup of the global pharmacy automation market based on the end-user?
  • 8. What are the key regions in the global pharmacy automation market?
  • 9. Who are the key players/companies in the global pharmacy automation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmacy Automation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Automated Medication Dispensing Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Automated Storage & Retrieval Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Automated Packaging & Labeling Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Tabletop Tablet Counters
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Dispensing and Packaging
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Storage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inventory Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Saudi Arabia
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Iran
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast
    • 9.5.4 United Arab Emirates
      • 9.5.4.1 Market Trends
      • 9.5.4.2 Market Forecast
    • 9.5.5 Others
      • 9.5.5.1 Market Trends
      • 9.5.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Baxter International Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Capsa Healthcare
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cerner Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Kirby Lester LLC
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 KUKA AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 McKesson Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Omnicell Technologies
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 RxSafe LLC
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Scriptpro LLC
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Swisslog Holding AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Takazono Corp.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
    • 13.3.13 Talyst LLC
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
    • 13.3.14 TCGRx Pharmacy Workflow Solutions
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
    • 13.3.15 Yuyama Co. Ltd.
      • 13.3.15.1 Company Overview
      • 13.3.15.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦